Protocol Deviation Placebo Parallel Study Phase I Phase IV Multicenter Trial Audit Trail Follow- up Visit Clinical Endpoint Blinding Control Group Protocol Pilot Study Regulatory Authority Data Lock Case Report Form (CRF) Patient Recruitment Double- Blind Study Standard Operating Procedure (SOP) Eligibility Criteria Investigator Meeting Principal Investigator Trial Monitor Screening Visit Trial Registry Institutional Review Board (IRB) Randomization Open- Label Trial Intervention Data Safety Monitoring Board (DSMB) Safety Profile Phase II Data Management Good Clinical Practice (GCP) Adverse Event Sponsor Crossover Study Surrogate Endpoint Source Data Verification Clinical Study Report (CSR) Ethics Committee Endpoint Clinical Research Coordinator Dropout Rate Phase III Efficacy Adaptive Design Informed Consent Recruitment Target Statistical Analysis Plan (SAP) Protocol Deviation Placebo Parallel Study Phase I Phase IV Multicenter Trial Audit Trail Follow- up Visit Clinical Endpoint Blinding Control Group Protocol Pilot Study Regulatory Authority Data Lock Case Report Form (CRF) Patient Recruitment Double- Blind Study Standard Operating Procedure (SOP) Eligibility Criteria Investigator Meeting Principal Investigator Trial Monitor Screening Visit Trial Registry Institutional Review Board (IRB) Randomization Open- Label Trial Intervention Data Safety Monitoring Board (DSMB) Safety Profile Phase II Data Management Good Clinical Practice (GCP) Adverse Event Sponsor Crossover Study Surrogate Endpoint Source Data Verification Clinical Study Report (CSR) Ethics Committee Endpoint Clinical Research Coordinator Dropout Rate Phase III Efficacy Adaptive Design Informed Consent Recruitment Target Statistical Analysis Plan (SAP)
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Protocol Deviation
Placebo
Parallel Study
Phase I
Phase IV
Multicenter Trial
Audit Trail
Follow-up Visit
Clinical Endpoint
Blinding
Control Group
Protocol
Pilot Study
Regulatory Authority
Data Lock
Case Report Form (CRF)
Patient Recruitment
Double-Blind Study
Standard Operating Procedure (SOP)
Eligibility Criteria
Investigator Meeting
Principal Investigator
Trial Monitor
Screening Visit
Trial Registry
Institutional Review Board (IRB)
Randomization
Open-Label Trial
Intervention
Data Safety Monitoring Board (DSMB)
Safety Profile
Phase II
Data Management
Good Clinical Practice (GCP)
Adverse Event
Sponsor
Crossover Study
Surrogate Endpoint
Source Data Verification
Clinical Study Report (CSR)
Ethics Committee
Endpoint
Clinical Research Coordinator
Dropout Rate
Phase III
Efficacy
Adaptive Design
Informed Consent
Recruitment Target
Statistical Analysis Plan (SAP)